Funding · Company
Cresilon, Inc.
Brooklyn, NYBiotech & Pharma
Cresilon, Inc. of Brooklyn, NY has disclosed $79M across 3 Form D offerings filed with the SEC between Oct 18, 2022 and Jun 26, 2026.
$79M
Total disclosed
3
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$29M
Form D · Jun 26, 2026 ↗
Q2 2026
· 1 amendment, first filed Apr 29, 2026
· target $29M
$25M
Form D · Jan 31, 2025 ↗
Q1 2025
· target $25M
$25M
Form D · Oct 18, 2022 ↗
Q4 2022
· target $25M
Filing details
HeadquartersBrooklyn, NYIndustryBiotech & Pharma (Biotechnology)SEC CIK0001728054Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →